Resverlogix Corp. (RVX : TSX)
Common Stock
$0.10
CAD
-0.01 (-5.00%)
Last updated: 2026-08-24
Get RVX alerts:
RVX
Resverlogix Corp.
WealthAwesomePerformance
1 Day
-5.00%
1 Week
+0.00%
1 Month
-9.52%
YTD
-5.00%
Key Statistics
Market Cap
$32.71M
52W High
$0.15
52W Low
$0.09
P/E Ratio
-
50 Day MA
$0.10
200 Day MA
$0.11
Beta
1.05
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 8/24/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 20,517 |
| 8/21/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 33,730 |
| 8/20/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 4,000 |
| 8/19/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 0 |
| 8/18/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 7,700 |
| 8/17/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 500 |
| 8/14/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 7,541 |
| 8/13/2026 | $0.10 | $0.11 | $0.10 | $0.10 | $0.10 | 65,000 |
| 8/12/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 1,084 |
| 8/11/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 2,950 |
Analyst Price Targets
Based on analyst covering RVX
Wall Street analysts forecast RVX stock price to rise 8005.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.70
+8005.3% Upside
Current Price
C$0.10
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on RVX's historical volatility
30-Day Vol
75.7%
Annualized
90-Day Vol
74.5%
Annualized
Trend (90d)
-0.0%
Annualized drift
90d Mean
C$0.09
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.09 | C$0.07 – C$0.12 |
| 60 trading days | C$0.09 | C$0.07 – C$0.14 |
| 90 trading days | C$0.09 | C$0.06 – C$0.15 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Resverlogix Corp.
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, type 2 diabetes mellitus, low high-density lipoprotein, recent acute coronary syndrome, and post COVID-19 conditions. The company has a partnership with Eversana Life Science Services, LLC to support the commercialization of apabetalone for COVID-19 in the United States and Canada; developing cardiovascular and pulmonary arterial hypertension indications; and Medison Pharma Ltd. The company is headquartered in Calgary, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-4.77M
- Profit Margin
- 0.00%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- -0.03
- Book Value
- -0.43
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About RVX
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
RVX.TO news timeline
15 articles covering RVX.TO, most recent first
LatestWhy Resverlogix Corp. stock plummeted yesterday
August 2026
July 2026
- Why Resverlogix Corp. stock surged yesterday
- Why Resverlogix Corp. stock is sliding today
- Why Resverlogix Corp. stock is sliding today
- Why Resverlogix Corp. stock surged yesterday
- What's Going On With Resverlogix Corp. Stock Thursday?
- Why Resverlogix Corp. stock is plummeting today
- What's Going On With Resverlogix Corp. Stock Thursday?
- Why Resverlogix Corp. stock is plummeting today